LightNews
jeanconnorsmd.bsky.social
@jeanconnorsmd.bsky.social
120 followers 72 following 16 posts
Posts Media Videos Starter Packs
Reposted
middeldorps.bsky.social
Saskia Middeldorp @middeldorps.bsky.social · Jun 21
Intriguing findings from a high-quality prospective study on SVT in #pregnancy and #postpartum. Incident higher, heterogeneous treatment, but low rate of #DVT and #PE. I was surprised and so were the authors. Would love to see the full results.

#ISTH2025
3 10
Reposted
gbarnesmd.bsky.social
Geoffrey Barnes, MD, MSc @gbarnesmd.bsky.social · Jun 24
MAQI2 data presented at #ISTH2025 shows significant cost reductions for warfarin patients in whom unnecessary aspirin was stopped. This supports the financial benefits of a key #AntithromboticStewardship intervention.
3 8
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Jun 25
@middeldorps.bsky.social I agree, excellent presentation about Claire and her accomplishments for women’s health
middeldorps.bsky.social
Saskia Middeldorp @middeldorps.bsky.social · Jun 21
What a fantastic plenary lecture by Prof Jennifer Curnow - in loving and admiring memory of my dear friend Dr Claire McLintock.

#ISTH2025
2
Reposted
tomreiser.bsky.social
Thomas Reiser @tomreiser.bsky.social · Jun 25
What an inspiring #ISTH2025!
It was wonderful to host the global #thrombosis & #hemostasis community in DC.
From the latest science & innovations to networking & building new collabs - it had it all!
Look out for recordings & other post- @isth.org congress updates.
Goodbye & see you @ #ISTH2026!
7 12
Reposted
middeldorps.bsky.social
Saskia Middeldorp @middeldorps.bsky.social · Jun 19
I have been quiet on the socials for a while, but very excited to be on my way to @isth.org #ISTH2025 ✈️. Let's hope that Bluesky gets to fly too!
And I also just realized that it has been 30 years since my first @isth.org meeting in 1995. I haven't missed one single congress. #thrombosis
1 3 13
Reposted
tomreiser.bsky.social
Thomas Reiser @tomreiser.bsky.social · Jun 20
💡Honoring the impact & memory of the late Claire McLintock, this @ISTH.org grant supports #ISTHEarlyCareer innovative research in women's health issues in #thrombosis & #hemostasis.
Learn more ⬇️and apply by ⏳ Sept. 1!
t.co/QYL9cUcoav
Thank you to all donors who supported this grant!
#ISTH2025
8 11
Reposted
middeldorps.bsky.social
Saskia Middeldorp @middeldorps.bsky.social · Jun 20
Great to be here! #ISTH2025. Looking forward to hearing and supporting all excellent science and scientists from all over the world. #thrombosis
1 3 13
Reposted
pamchmd.bsky.social
Pamela Contreras Chavez @pamchmd.bsky.social · Jun 1
So fun connecting with colleagues in #ASCO25 meeting! Diversity is key.
Missing my mentor @jeanconnorsmd.bsky.social !!! trainees from Peru and Mexico interested in Heme!
1 2
Reposted
thrombosisdr.bsky.social
Roopen Arya @thrombosisdr.bsky.social · May 25
Pregnancy-Related VTE Risk Perception & Prevention in Risk-Averse Times—Significant Change Required vimeo.com/1072760896 @btsamuelsonmd.bsky.social @marccarriermd.bsky.social @isth.org @worldthrombosisday.bsky.social @thrombosisuk.bsky.social @jeanconnorsmd.bsky.social @bsochaem.bsky.social
Video abstract - VTE prevention strategy - 20250320
Pregnancy-related venous thromboembolism risk perception and prevention in risk-averse times - significant change required; a commentary
vimeo.com
6 5
Reposted
physiciandemocracy.medsky.social
Physicians for a Healthy Democracy @physiciandemocracy.medsky.social · May 17
www.harvardmagazine.com/2025/05/heal...
Addressing Gaps in Care for Patients with Disabilities | Harvard Magazine
Lisa Iezzoni explores the unmet needs of patients with disabilities.
www.harvardmagazine.com
4 24 93
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 30
Delighted to see @pamchmd.bsky.social in Chicago. Great mentee. Is colleague!
pamchmd.bsky.social
Pamela Contreras Chavez @pamchmd.bsky.social · Mar 30
Super happy to have seen my mentor in Chicago!!! @jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 30
Connected with @pamchmd while at @acc25. Former Boston heme fellow now Chicago attending
2
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 30
Connected with @pamchmd while at @acc25. Former Boston heme fellow now Chicago attending
3
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 29
@acc25.bsky.social #acc25
#medsky wonderful to see friends and colleagues in person!
5
Reposted
washingtonpost.com
The Washington Post @washingtonpost.com · Mar 29
The Trump administration pushed out Peter Marks, the nation’s top vaccine regulator and an architect of the U.S. program to rapidly develop coronavirus vaccines.
RFK Jr. forces out Peter Marks, FDA’s top vaccine scientist
In his resignation letter, Marks rebuked Kennedy for seeking “subservient confirmation of his misinformation and lies” about vaccines.
wapo.st
52 130 260
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 29
@acc25.bsky.social Isabelle Mahe presents API-CAT
Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
3 8
Reposted
jaccjournals.bsky.social
JACC Journals @jaccjournals.bsky.social · Mar 29
💡 #Semaglutide is the first therapy to ⬇️ #MACE, improve cardiometabolic and kidney outcomes and improves walking capacity, symptoms, and related #QoL in patients with #cvPAD and #T2D

#ACC25 #JACCJournals #CardioSky
jaccjournals.bsky.social
JACC Journals @jaccjournals.bsky.social · Mar 29
Dr. Marc Bonaca on the effect of once-weekly subcutaneous #semaglutide on functional capacity in people with #T2D and #cvPAD

#ACC25 #JACCJournals
6 6
Reposted
gregggonsalves.bsky.social
Gregg Gonsalves @gregggonsalves.bsky.social · Mar 29
Read Peter Marks' resignation letter from FDA. Shame on #RFKJr, #Trump, #Musk, #Vought and the rest of these monsters driving the American public health and health systems to destruction.
enirenberg.bsky.social
Edward Nirenberg @enirenberg.bsky.social · Mar 29
Peter Marks’s resignation letter. Everyone should read this.
Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20903 March 28, 2025 Sara Brenner, MD, MPH Acting Commissioner of Food and Drugs U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20903 Dear Dr. Brenner: It is with a heavy heart that I have decided to resign from FDA and retire from federal service as Director of the Center for Biologics Evaluation and Research effective April 5, 2025. I leave behind a staff of professionals who are undoubtedly the most devoted to protecting and promoting the public health of any group of people that I have encountered during my four decades working in the public and private sectors. I have always done my best to advocate for their well-being and I would ask that you do the same during this very difficult time during which their critical importance to the safety and security of our nation may be underappreciated. Over the past years I have been involved in enhancing the safety of our nation's blood supply, in advancing the field of cell and gene therapy, and in responding to public health emergencies. In the last of these, during the COVID-19 pandemic I had the privilege of watching the vision that I conceived for Operation Warp Speed in March 2020 in collaboration with Dr. Robert Kadlec become a reality under the leadership of HHS Secretary Azar and President Trump due to the unwavering commitment of public servants at FDA and elsewhere across the government. At FDA, the tireless efforts of staff across the agency resulted in remarkably expediting the development of vaccines against the virus, meeting the standards for quality, safety, and effectiveness expected by the American public. The vaccines undoubtedly markedly reduced morbidity and mortality from COVID-19 in the United States and elsewhere. Many of these same individuals applied learnings from the pandemic during a flawless response helping… ongoing multistate measles outbreak that is particularly severe in Texas reminds us of what happens when confidence in well-established science underlying public health and well-being is undermined. Measles, which killed more than 100,000 unvaccinated children last year in Africa and Asia owing to pneumonitis and encephalitis caused by the virus, had been eliminated from our shores. The two-dose measles, mumps, rubella vaccine regimen (MMR) using over the past decades has a remarkably favorable benefit-risk profile. The MMR vaccine is 97% or more effective in preventing measles following the two-dose series, and its safety has been remarkably well studied. Though rarely followed by a single fever-related seizure, or very rarely by allergic reactions or blood clotting disorders, the vaccine very simply does not cause autism, nor is it associated with encephalitis or death. It does, however, protect against a potential devasting consequence of prior measles infection, subacute sclerosing panencephalitis (SSPE), which is an untreatable, relentlessly progressive neurologic disorder leading to death in about 1 in 10,000 individuals infected with measles. Undermining confidence in well-established vaccines that have met the high standards for quality, safety, and effectiveness that have been in place for decades at FDA is irresponsible, detrimental to public health, and a clear danger to our nation's health, safety. and security. In the years following the pandemic, at the Center for Biologics Evaluation and Research we have applied the same unwavering commitment to public health priorities to the development of cell and gene therapies to address both hereditary and acquired rare diseases. During my tenure as Center Director we have approved 22 gene therapies, including the first gene therapy ever to be approved in the United States. However, we know that we must do better to expedite the development of treatments for those individual suffering from any one of the thousan…
7 68 190
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 29
@acc25.bsky.social
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 29
ACC25 Mark Bonaca presenting onsemiglutide on pad improvement in the STRIDE trial—clear success
1
jeanconnorsmd.bsky.social
jeanconnorsmd.bsky.social @jeanconnorsmd.bsky.social · Mar 29
ACC25 Mark Bonaca presenting onsemiglutide on pad improvement in the STRIDE trial—clear success
2
Reposted
joncooper-us.bsky.social
Jon Cooper @joncooper-us.bsky.social · Mar 28
👇👇
450 8.7K 27K
Reposted
worldthrombosisday.bsky.social
World Thrombosis Day @worldthrombosisday.bsky.social · Mar 24
It’s #BloodClotAwarenessMonth. Do your patients know the signs and symptoms of blood clots? Encourage them to learn more about blood clots at www.getouttheclot.com/patient/

#VTEAwareness #WTDay25
Patient - Get Out the Clot
I just took the #GetOutTheClot pledge to improve care for patients with VTE. By uniting with fellow healthcare professionals, we can help patients receive the right treatment at the right time with ac...
www.getouttheclot.com
6 8
Reposted
dianvanderwaldr.bsky.social
Dianne @dianvanderwaldr.bsky.social · Mar 24
#hemesky 🩸
Congratulations to these excellent winners 🎊🏆🏅
@jthjournal.bsky.social
isth.org
International Society on Thrombosis and Haemostasis @isth.org · Mar 24
📢 @jthjournal.bsky.social is proud to announce the recipients of the 2025 JTH Editors’ Awards!

These prestigious awards honor six outstanding early career investigators for their top articles in thrombosis and hemostasis. Join us in congratulating the winners🎉 and learn more here: bit.ly/4lc2pFR
2 8
Reposted
profgalloway.com
Scott Galloway @profgalloway.com · Mar 24
Don’t drink and text.
340 5.9K 27K
Reposted
jacquelyngill.bsky.social
Jacquelyn Gill @jacquelyngill.bsky.social · Mar 23
This is such an important distinction! It’s also what universities are failing to understand, and it’s not going to save them in the end.
nbedera.bsky.social
Nicole Bedera @nbedera.bsky.social · Mar 7
I’ve seen a lot of assumptions in the media that Trump (and Musk) are targeting institutions with loyalty tests.

But that’s not quite right. They’re using dominance tests. And the difference between these two things matter. 🧵
1 27 100
Reposted
isth.org
International Society on Thrombosis and Haemostasis @isth.org · Mar 20
Exciting news! 🎉We’re thrilled to announce the recipients of the 2025 Outstanding Mentor Awards: Denisa Wagner & Robert Medcalf. These awards honor mentors who go above and beyond to inspire, guide & empower early career professionals in thrombosis & hemostasis.

Learn more: bit.ly/41FIZQz
2 9